This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Circulation, Ahead of Print. This American Heart Association/American College of Cardiology scientific statement on clinical considerations for competitive sports participation for athletes with cardiovascular abnormalities or diseases is organized into 11 distinct sections focused on sports-specific topics or disease processes that are relevant when considering the potential risks of adverse cardiovascular events, including sudden cardiac arrest, during competitive sports participation.
IntroductionERAS protocols have revolutionized perioperative care by optimizing patient outcomes after major surgeries. Despite widespread recognition in various surgical specialties, the implementation of ERAS in cardiac surgery remains relatively novel.MethodsThis qualitative study employed semi-structured interviews to explore the perspectives and experiences of healthcare professionals involved in ERAS implementation, focusing on identifying facilitators and barriers.
Circulation, Ahead of Print. BACKGROUND:Circular RNAs derived from both nuclear and mitochondrial genomes are identified in animal cells. Mitochondria-encoded circular RNAs (mecciRNAs) are attracting more attention, and several members of mecciRNAs have already been recognized in regulating mitochondrial functions. Mitochondria dysfunctions are well-known to participate in heart failure (HF).
Hypertension (high blood pressure) is a debilitating condition and a major cause of premature death worldwide. Chronic stress plays a significantrole, but the underlying mechanism involving biochemical pathways by which stress leads to hypertension has not been well understood. Understanding these pathways could lead to the development of therapeutic agents to combat hypertension.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
These data were the result of a new network meta-analysis looking specifically at children with eczema, highlighting the hierarchy of effectiveness among systemic drugs.
A new study shows how the brain reorganizes itself in the first few months after a stroke to improve the ability to speak again. The findings will help researchers understand how functional networks work in the brain. They also have the potential to be used in the future for personalized treatment of stroke patients.
SGLT2 inhibitors may slow the progression of nonsevere aortic stenosis (AS), according to a study published Feb. 19 in JACC: Cardiovascular Interventions.
SGLT2 inhibitors may slow the progression of nonsevere aortic stenosis (AS), according to a study published Feb. 19 in JACC: Cardiovascular Interventions.
Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.
(MedPage Today) -- The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in adults with type 2 diabetes, according to a retrospective study. In this review of 37.1 million patients.
A new study, authored by KBH Professor Jan Inge Henter and published in the New England Journal of Medicine, has investigated whether the drug empagliflozin can reduce the risk of heart failure and death in patients who have recently suffered a heart attack.
(MedPage Today) -- Cancer diagnoses tended to arise more in patients who bled on oral anticoagulants (OACs), a Canadian population-based cohort study found. In Ontario, people with atrial fibrillation (Afib) on OAC therapy had a 21.8% incidence.
Shared decision-making between clinicians and athletes of all ages who have cardiovascular abnormalities and want to participate in competitive sports is essential, according to a new joint scientific statement.
Low and high second-trimester eGFR values were linked to adverse pregnancy outcomes, including preeclampsia, preterm birth, low birth weight, and fetal loss.
The hyperpolarization-activated cyclic nucleotide-gated channel 4 (HCN4) drives the funny current (If) in cardiac pacemaker regions. Its involvement in sinoatrial node pacemaker generation is well-known, but its function in the atrioventricular (AV) node (AVN) has not intensively been studied. HCN4 is expressed in the AVN and its expression within the AVN seems similar across mammalian species with HCN4 presence in the inferior nodal extensions, compact node, and atrioventricular bundle.
Alpyns Investigational New Drug applications clearance by the FDA for the new Zabalafin Hydrogel for atopic dermatitis follows positive phase 2a clinical findings.
A new joint Scientific Statement from the American Heart Association (AHA) and the ACC provides new and updated clinical guidance on how to assess risk when considering competitive sports participation for people with various cardiovascular conditions.
The multidisciplinary care model included 7 co-located specialists who aided patient education, lifestyle intervention, and drug therapy strategies for MASH.
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Germans Trias i Pujol Research Institute (IGTP) have studied variations in mRNA length during the progression of atherosclerosis in a mouse model. The results, published in the journal Biomedicines, could help identify new biomarkers and potential therapeutic targets.
A 46-member expert panel created a consensus anaphylaxis definition, overview, and clinical tool to aid clinicians in recognition and management across settings.
A unique international task force, comprised of representatives from cardiology and cardiothoracic societies as well as patient representatives, has developed the first standardized set of measures for heart valve disease (HVD).
This genome-wide meta-analysis demonstrated that changes in 2 parts of the genome both work to influence patients risk of frontal fibrosing alopecia (FFA).
The objective of this study is to examine the therapeutic efficacy of miR-133a-transfected bone marrow mesenchymal stem cells (BM-MSCs) in restoring damaged myocardium, reducing myocardial fibrosis, and improv.
Clark describes visual and anatomic improvements with aflibercept 8 mg in the PULSAR extension study, with most patients achieving extended dosing regimens.
Solitary fibrous tumor (SFT) is a rare condition first described by Klemperer and Robin in 1931. Malignant SFTs account for approximately 80% of all SFT cases, and the five-year survival for malignant SFTs is.
Body position can affect the accuracy of vital sign measurements that indicate arterial stiffnessa risk factor for heart diseaseaccording to new research. Sitting down during certain tests may cause a spike in arterial stiffness readings that does not reflect a true increase.
Sphingosine 1-phosphate (S1P) is a key mediator of lipid signaling with strong immunomodulatory and anti-inflammatory effects. Circulating S1P levels including S1P in high-density lip.
The AHOMKA platform, an innovative mobile app for patient-to-provider communication that was developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results in tests with patients at high risk for heart attack or stroke.
Dysglycaemia is a known risk factor for cardiovascular disease and microcirculatory dysfunction is associated with an increased cardiovascular disease risk. The aim of this study was to investigate the prevale.
Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complications due to its invasive nature. Researchers have now found a way to combine right ventricular (RV) septal EMB, exploiting the benefit of 3D curved conduction system pacing (CSP) sheaths, with subsequent cardiac implantable electronic device (CIED, devices like pacemakers or defibrillators to regulate heart rhythm) implantation, using the same sheath.
Cardiovascular disease is a leading cause of post-transplant mortality in kidney transplant recipients (KTRs), especially those with diabetes. Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) hav.
Traditional risk factors cannot accurately predict cardiovascular events (CVE) in type 2 diabetes (T2D). The LIPOCAT study aimed to prospectively evaluate the clinical utility of advanced lipoprotein character.
"Discover the new state-of-the-art cardiovascular intensive care unit at Children's Hospital of Orange County, equipped with advanced monitoring and rehabilitat
Panelists discuss how Bruton tyrosine kinase (BTK) inhibition could effectively treat both autoallergic and autoimmune chronic spontaneous urticaria (CSU).
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
81 
Let's personalize your content